FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3155911000001103: Terazosin 5mg tablets (Approved Prescription Services) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17278101000001115 Terazosin 5mg tablets (Approved Prescription Services) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38163201000001118 Terazosin 5mg tablets (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Terazosin 5mg tablets (Approved Prescription Services) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) Is a Product containing precisely terazosin (as terazosin hydrochloride) 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) Has active ingredient Terazosin hydrochloride false Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Terazosin true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) Has specific active ingredient Terazosin hydrochloride true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) Has basis of strength substance Terazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Terazosin 5mg tablets (Approved Prescription Services) 28 tablet 2 x 14 tablets Is pack of False Terazosin 5mg tablets (Approved Prescription Services) Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Approved Prescription Services) 28 tablet 2 x 14 tablets Has AMP True Terazosin 5mg tablets (Approved Prescription Services) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start